BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10524199)

  • 1. Myb and Ets transcription factors cooperate at the myb-inducible promoter of the tom-1 gene.
    Burk O; Klempnauer KH
    Biochim Biophys Acta; 1999 Sep; 1446(3):243-52. PubMed ID: 10524199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the ets genes and their products.
    Watson DK; Ascione R; Papas TS
    Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
    Burk O; Worpenberg S; Haenig B; Klempnauer KH
    EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
    Hagman J; Grosschedl R
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
    Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
    Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Back-mutation of the V-Ets to the C-Ets carboxy-terminal amino acids in the P135gag-myb-ets results in chicken neuroretina cells transformation and loss of basic fibroblast growth factor responsiveness.
    Garrido C; Leprince D; Plaza S; Aumercier M; Stéhelin D; Saule S
    Oncogene; 1996 Apr; 12(7):1449-56. PubMed ID: 8622861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter.
    Geng CD; Vedeckis WV
    J Biol Chem; 2005 Dec; 280(52):43264-71. PubMed ID: 16263717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter.
    Dudek H; Tantravahi RV; Rao VN; Reddy ES; Reddy EP
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1291-5. PubMed ID: 1741383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1.
    McNagny KM; Sieweke MH; Döderlein G; Graf T; Nerlov C
    EMBO J; 1998 Jul; 17(13):3669-80. PubMed ID: 9649437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myb and Ets proteins cooperate to transactivate an early myeloid gene.
    Shapiro LH
    J Biol Chem; 1995 Apr; 270(15):8763-71. PubMed ID: 7721782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA binding by c-Ets-1, but not v-Ets, is repressed by an intramolecular mechanism.
    Lim F; Kraut N; Framptom J; Graf T
    EMBO J; 1992 Feb; 11(2):643-52. PubMed ID: 1311254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new mechanism of oncogenic activation: E26 retroviral v-ets oncogene has inverted the C-terminal end of the transcription factor c-ets-1.
    Leprince D; Crepieux P; Laudet V; Flourens A; Stehelin D
    Virology; 1993 Jun; 194(2):855-7. PubMed ID: 8389086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
    Rascle A; Ferrand N; Gandrillon O; Samarut J
    Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transactivation of the GATA-1 promoter by a myb-ets-containing mouse retrovirus is mediated by CACCC elements.
    Sun-Hoffman L; Aurigemma RE; Sun B; Ruscetti SK
    Oncogene; 1996 Sep; 13(5):1037-42. PubMed ID: 8806693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
    Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ
    EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. erg, an ets-related gene, codes for sequence-specific transcriptional activators.
    Reddy ES; Rao VN
    Oncogene; 1991 Dec; 6(12):2285-9. PubMed ID: 1766675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ets-2 and c-Myb act independently in regulating expression of the hematopoietic stem cell antigen CD34.
    Melotti P; Calabretta B
    J Biol Chem; 1994 Oct; 269(41):25303-9. PubMed ID: 7523384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myb and ets proteins are candidate regulators of c-kit expression in human hematopoietic cells.
    Ratajczak MZ; Perrotti D; Melotti P; Powzaniuk M; Calabretta B; Onodera K; Kregenow DA; Machalinski B; Gewirtz AM
    Blood; 1998 Mar; 91(6):1934-46. PubMed ID: 9490676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
    Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
    Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the human leukemia inhibitory factor gene by ETS transcription factors.
    Bamberger AM; Jenatschke S; Schulte HM; Ellebrecht I; Beil FU; Bamberger CM
    Neuroimmunomodulation; 2004; 11(1):10-9. PubMed ID: 14557674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.